Alcresta Therapeutics CEO and leadership

Q: Who is the CEO of Alcresta Therapeutics?

The CEO of Alcresta Therapeutics is Daniel Orlando.

Q: Who is the founder of Alcresta Therapeutics?

Robert Gallotto and Shaheda Ahmed founded Alcresta Therapeutics.

Zippia score 4.1

Alcresta Therapeutics CEO and executives

Executive Summary. Based on our data team's research, Daniel Orlando is the Alcresta Therapeutics's CEO. Alcresta Therapeutics has 36 employees, of which 16 are in a leadership position.

Here are further demographic highlights of the leadership team:

The Alcresta Therapeutics executive team is 13% female and 88% male.
65% of the management team is White.
11% of Alcresta Therapeutics management is Hispanic or Latino.
10% of the management team is Black or African American.

Work at Alcresta Therapeutics?

Share your experience

Rate Alcresta Therapeutics' leadership communication with employees.

Name & TitleBio

Daniel Orlando

CEO

Daniel 'Dan' Orlando is a Board Member at Alcresta Therapeutics and CEO at Alcresta Therapeutics and is based in Cambridge, Massachusetts. He has worked as Chief Business Officer at VERICEL CORP; Chief Commercial Officer at VERICEL CORP; and Vice President, Business Development at Takeda. Daniel studied at University of Florida between 1986 and 1987 and Florida Atlantic University between 1990 and 1991.

Robert Gallotto

Founder

Shaheda Ahmed

Founder

Jason Weiner

Chief Commercial Officer

Jason Weiner is a Chief Commercial Officer at Alcresta Therapeutics and is based in Greater Boston Area. He has worked as Professional Representative at Pfizer; Principal at CRA INTERNATIONAL, INC.; and Senior Associate at CRA INTERNATIONAL, INC.. Jason works or has worked as Director of Marketing and Market Access at VERICEL CORP and Director of Payer Optimization at VERICEL CORP. He studied at Union College between 1999 and 2002 and Boston College - Wallace E. Carroll Graduate School of Management between 2007 and 2009.

Stephen Kraus

Board Member

Steve Dubin

Board Member

Todd Creech

Board Member

William Scheinler

Chief Legal and Compliance Officer and Secretary

William Scheinler is the Chief Legal Officer at Alcresta Therapeutics. Prior to that, he was the Vice President, Associate General Counsel for Ikaria.

Alan Muney M.d

Board Member

Alexey Margolin

Board Member

Do you work at Alcresta Therapeutics?

Does the leadership team provide a clear direction for Alcresta Therapeutics?

Alcresta Therapeutics jobs

Alcresta Therapeutics founders

Name & TitleBio

Robert Gallotto

Founder

Shaheda Ahmed

Founder

Alcresta Therapeutics board members

Name & TitleBio

Daniel Orlando

CEO

Stephen Kraus

Board Member

Steve Dubin

Board Member

Todd Creech

Board Member

Alan Muney M.d

Board Member

Alexey Margolin

Board Member

James Topper

Board Member

Robert Tepper

Board Member

Alcresta Therapeutics executives FAQs

Who is the CEO of Alcresta Therapeutics?

Who is the founder of Alcresta Therapeutics?

Most in demand jobs

Companies
Massachusetts
Newton, MA
Alcresta Therapeutics
Alcresta Therapeutics Executives

Updated November 18, 2022

Zippia gives an in-depth look into the details of Alcresta Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Alcresta Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Alcresta Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Alcresta Therapeutics. The data presented on this page does not represent the view of Alcresta Therapeutics and its employees or that of Zippia.

Alcresta Therapeutics may also be known as or be related to Alcresta, Alcresta Therapeutics, Alcresta Therapeutics Inc and Alcresta Therapeutics, Inc.